Becton Dickinson notches a partial win in its $352 million anti-trust loss to Retractable Technologies after a federal judge says it can delay notifying end users about its false advertising for its pre-filled syringes.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1G9dtNn
Cap comentari:
Publica un comentari a l'entrada